Novo Nordisk has launched a once-daily Wegovy pill, marking the first oral GLP-1 medication approved for weight loss in the United States. This development provides a new option for consumers seeking alternatives to injectable treatments, which have experienced significant demand.
Jean-Luc Maracon is a French-Swiss expert in decentralized finance, known for his sharp analysis of Bitcoin, European Web3 projects, and crypto regulatory challenges. Splitting his time between Geneva and Paris, he brings a unique perspective blending traditional finance with blockchain innovation. He regularly collaborates with crypto platforms across Europe to help make digital investing more accessible. Specialties: Bitcoin, staking, European regulation, crypto security, Web3.
Get the latest Crypto & Blockchain News in your inbox.
